The estimated Net Worth of Jeffrey L Edwards is at least $582 Tisíc dollars as of 7 June 2023. Mr. Edwards owns over 7,889 units of FibroGen Inc stock worth over $13,591 and over the last 9 years he sold FGEN stock worth over $135,612. In addition, he makes $433,065 as Independent Director at FibroGen Inc.
Jeffrey has made over 1 trades of the FibroGen Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 7,889 units of FGEN stock worth $135,612 on 7 June 2023.
The largest trade he's ever made was selling 7,889 units of FibroGen Inc stock on 7 June 2023 worth over $135,612. On average, Jeffrey trades about 359 units every 0 days since 2015. As of 7 June 2023 he still owns at least 33,977 units of FibroGen Inc stock.
You can see the complete history of Mr. Edwards stock trades at the bottom of the page.
Jeffrey L. Edwards serves as Independent Director of the Company. Mr. Edwards was appointed to our board of directors in 2015 after Mr. Edwards retired from Allergan, Inc. Mr. Edwards served as Executive Vice President, Finance and Business Development, Chief Financial Officer of Allergan, Inc. from September 2005 to August 2014. Mr. Edwards joined Allergan in 1993. From 2003 to 2005, Mr. Edwards served as Allergan’s Corporate Vice President, Corporate Development and previously served as Senior Vice President, Treasury, Tax and Investor Relations. Prior to joining Allergan, Mr. Edwards was with Banque Paribas and Security Pacific National Bank, where he held various senior-level positions in the credit and business development functions. In addition to being on the board of directors of the Company, Mr. Edwards currently serves as Compensation Committee Chairman of Bio-Rad Laboratories, Inc., a publicly traded life sciences research and clinical diagnostic products company. Mr. Edwards also serves on the board of directors and Compensation Committee of Clearside Biomedical Inc., a publicly traded, development stage pharmaceutical company. Mr. Edwards received a Bachelor of Arts degree in Sociology from Muhlenberg College and completed the Advanced Management Program at the Harvard Business School.
As the Independent Director of FibroGen Inc, the total compensation of Jeffrey Edwards at FibroGen Inc is $433,065. There are 12 executives at FibroGen Inc getting paid more, with Kin-Hung Yu having the highest compensation of $5,856,450.
Jeffrey Edwards is 59, he's been the Independent Director of FibroGen Inc since 2015. There are 10 older and 11 younger executives at FibroGen Inc. The oldest executive at FibroGen Inc is Thomas Kearns, 83, who is the Lead Independent Director.
Jeffrey's mailing address filed with the SEC is C/O CLEARSIDE BIOMEDICAL, INC., 900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GA, 30005.
Over the last 10 years, insiders at FibroGen Inc have traded over $188,593,537 worth of FibroGen Inc stock and bought 106,523 units worth $1,309,423 . The most active insiders traders include Rory B Riggs, Thomas B Neff a Jeffrey William Henderson. On average, FibroGen Inc executives and independent directors trade stock every 8 days with the average trade being worth of $6,963. The most recent stock trade was executed by Deyaa Adib on 12 June 2024, trading 22,123 units of FGEN stock currently worth $25,884.
fibrogen is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. the company has built upon its extensive research experience in fibrosis and hypoxia-inducible factor (hif) biology to generate clinical programs targeting multiple therapeutic areas. fibrogen's most advanced product candidate, roxadustat (fg-4592), is an oral small molecule inhibitor of hif prolyl hydroxylases (hif-phs), in phase 3 clinical development for the treatment of anemia in chronic kidney disease (ckd). our second product candidate, fg-3019, is a monoclonal antibody in phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (ipf), pancreatic cancer and liver fibrosis. for more information please visit: www.fibrogen.com.
FibroGen Inc executives and other stock owners filed with the SEC include: